The role of radiation therapy to the primary site in locally advanced and metastatic pancreatic cancer ( 2004-2015 National Cancer Data Base (NCDB) review).

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e16257-e16257
Author(s):  
Nibal Saad ◽  
Shreya Sinha ◽  
Wajihuddin Syed ◽  
Adham Adel Jurdi
2016 ◽  
Vol 124 (11) ◽  
pp. 791-800 ◽  
Author(s):  
Ted Gansler ◽  
Stacey A. Fedewa ◽  
Chun Chieh Lin ◽  
Ahmedin Jemal ◽  
Elizabeth M. Ward

2021 ◽  
pp. 20210044
Author(s):  
Florence Huguet ◽  
Victoire Dabout ◽  
Eleonor Rivin del Campo ◽  
Sébastien Gaujoux ◽  
Jean Baptiste Bachet

At diagnosis, about 15% of patients with pancreatic cancer present with a resectable tumour, 50% have a metastatic tumour, and 35% a locally advanced tumour, non-metastatic but unresectable due to vascular invasion, or borderline resectable. Despite the technical progress made in the field of radiation therapy and the improvement of the efficacy of chemotherapy, the prognosis of these patients remains very poor. Recently, the role of radiation therapy in the management of pancreatic cancer has been much debated. This review aims to evaluate the role of radiation therapy for patients with locally advanced tumours.


Sign in / Sign up

Export Citation Format

Share Document